Woodrow D. Anderson, Chief Accounting Officer at Indivior Pharmaceuticals, Inc. (INDV), bought 1,500 shares at $35.69 ($54K) on 2026-08-27, disclosed to the SEC on 2026-08-27.
Open-market purchase of $54k INDV by Chief Accounting Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.